Silverfin false false 31/12/2025 01/01/2025 31/12/2025 Kenneth Robert Woodburn 10/06/2016 15 March 2026 The principal activity of the Company during the financial year was that of a vascular consultant. 10225678 2025-12-31 10225678 bus:Director1 2025-12-31 10225678 2024-12-31 10225678 core:CurrentFinancialInstruments 2025-12-31 10225678 core:CurrentFinancialInstruments 2024-12-31 10225678 core:ShareCapital 2025-12-31 10225678 core:ShareCapital 2024-12-31 10225678 core:RetainedEarningsAccumulatedLosses 2025-12-31 10225678 core:RetainedEarningsAccumulatedLosses 2024-12-31 10225678 core:PlantMachinery 2024-12-31 10225678 core:OfficeEquipment 2024-12-31 10225678 core:PlantMachinery 2025-12-31 10225678 core:OfficeEquipment 2025-12-31 10225678 bus:OrdinaryShareClass1 2025-12-31 10225678 2025-01-01 2025-12-31 10225678 bus:FilletedAccounts 2025-01-01 2025-12-31 10225678 bus:SmallEntities 2025-01-01 2025-12-31 10225678 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 10225678 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 10225678 bus:Director1 2025-01-01 2025-12-31 10225678 core:PlantMachinery 2025-01-01 2025-12-31 10225678 core:OfficeEquipment 2025-01-01 2025-12-31 10225678 2024-01-01 2024-12-31 10225678 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 10225678 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 10225678 (England and Wales)

# CORNWALL VEIN CLINIC LIMITED

### Unaudited Financial Statements
For the financial year ended 31 December 2025
Pages for filing with the registrar

CORNWALL VEIN CLINIC LIMITED

## Unaudited Financial Statements

For the financial year ended 31 December 2025

Contents

CORNWALL VEIN CLINIC LIMITED

## BALANCE SHEET

As at 31 December 2025
CORNWALL VEIN CLINIC LIMITED

## BALANCE SHEET (continued)

As at 31 December 2025

| Note | 2025 |  | 2024
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 3 | 4,282 |  | 4,216
|  | 4,282 |  | 4,216
Current assets |  |  |  |
Debtors | 4 | 1,243 |  | 15,796
Cash at bank and in hand |  | 39,494 |  | 53,607
|  | 40,737 |  | 69,403
Creditors: amounts falling due within one year | 5 | ( 2,653) |  | ( 7,330)
Net current assets |  | 38,084 |  | 62,073
Total assets less current liabilities |  | 42,366 |  | 66,289
Provision for liabilities |  | ( 801) |  | ( 801)
Net assets |  | 41,565 |  | 65,488
Capital and reserves |  |  |  |
Called-up share capital | 6 | 1,000 |  | 1,000
Profit and loss account |  | 40,565 |  | 64,488
Total shareholders' funds |  | 41,565 |  | 65,488

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of Cornwall Vein Clinic Limited (registered number: 10225678) were approved and authorised for issue by the Director on 15 March 2026. They were signed on its behalf by:

Kenneth Robert Woodburn Director |

CORNWALL VEIN CLINIC LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
CORNWALL VEIN CLINIC LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

##### General information and basis of accounting

Cornwall Vein Clinic Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Lowin House, Tregolls Road, Truro, TR1 2NA, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Revenue from services is recognised as they are delivered.

##### Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

##### Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a [straight-line, reducing balance] basis over its expected useful life, as follows:

Plant and machinery | 20 % reducing balance
Office equipment | 20 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

##### Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

##### Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
The company has chosen to apply the recognition and measurement principles in FRS102.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.
Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.
Other basic financial liabilities are measured at amortised cost.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

##### Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).
When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

#### 2. Employees

| 2025 |  | 2024
| Number |  | Number
Monthly average number of persons employed by the Company during the year, including the director | 0 |  | 0

#### 3. Tangible assets

| Plant and machinery |  | Office equipment |  | Total
| £ |  | £ |  | £
Cost |  |  |  |  |
At 01 January 2025 | 11,368 |  | 8,227 |  | 19,595
Additions | 0 |  | 1,270 |  | 1,270
Disposals | ( 206) |  | ( 1,093) |  | ( 1,299)
At 31 December 2025 | 11,162 |  | 8,404 |  | 19,566
Accumulated depreciation |  |  |  |  |
At 01 January 2025 | 9,648 |  | 5,731 |  | 15,379
Charge for the financial year | 337 |  | 631 |  | 968
Disposals | ( 172) |  | ( 891) |  | ( 1,063)
At 31 December 2025 | 9,813 |  | 5,471 |  | 15,284
Net book value |  |  |  |  |
At 31 December 2025 | 1,349 |  | 2,933 |  | 4,282
At 31 December 2024 | 1,720 |  | 2,496 |  | 4,216

#### 4. Debtors

| 2025 |  | 2024
| £ |  | £
Trade debtors | 298 |  | 13,140
Corporation tax | 801 |  | 0
Other debtors | 144 |  | 2,656
| 1,243 |  | 15,796

#### 5. Creditors: amounts falling due within one year

| 2025 |  | 2024
| £ |  | £
Trade creditors | 0 |  | 204
Taxation and social security | 0 |  | 5,140
Other creditors | 2,653 |  | 1,986
| 2,653 |  | 7,330

#### 6. Called-up share capital

| 2025 |  | 2024
| £ |  | £
Allotted, called-up and fully-paid |  |  |
1,000 Ordinary shares of £ 1.00 each | 1,000 |  | 1,000

#### 7. Related party transactions

Transactions with the entity's director

| 2025 |  | 2024
| £ |  | £
Directors Loan Account | (463) |  | 2,523

During the year the Company advanced £85 to the directors (2024 - £3,698), of which £3,071 was repaid (2023 - £1,175). Interest was charged on this amount at the official HMRC rate and the balance is repayable on demand. The balance owed by the company at 31 December 2025 is £463 (2024 - £(2,523)).